Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.9981
-0.1619 (-13.96%)
At close: Apr 1, 2025, 4:00 PM
1.040
+0.042 (4.19%)
After-hours: Apr 1, 2025, 4:58 PM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $1.46 million as of April 1, 2025. Its market cap has decreased by -44.01% in one year.
Market Cap
1.46M
Enterprise Value
-1.81M
1-Year Change
-44.01%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.90M to $1.46M, a decrease of -99.10%. That is a compound annual growth rate of -41.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.60M | -27.27% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.43% |
| Dec 31, 2021 | 38.60M | -74.59% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.28% |
| Dec 29, 2017 | 90.80M | 83.81% |
| Dec 30, 2016 | 49.40M | -69.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |